⌘K

Login Start Free

Home/Filings/4/0001209191-22-054512

4//SEC Filing

Rochlin Kate 4

Accession 0001209191-22-054512

CIK 0001740279other

View on SEC.gov Company Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 4:35 PM ET

Size

5.5 KB

Accession

0001209191-22-054512

Insider Transaction Report

Form 4

Period: 2022-10-21

IN8BIO, INC.INAB

Chief Operating Officer

Transactions

Award
Employee Stock Option (right to buy)
2022-10-21+60,555→ 60,555 total
Exercise: $1.48Exp: 2032-10-21→ Common Stock (60,555 underlying)

Footnotes (1)

[F1]The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1

filerCIK 0001898521

Filing Metadata

Form type: 4
Filed: Oct 24, 8:00 PM ET
Accepted: Oct 25, 4:35 PM ET
Size: 5.5 KB

View on SEC.gov